PATENT CLAIM ANALYSIS

Application Number: 16009527
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "350000"]

Abstract:
A pharmaceutically acceptable transdermal composition for the treatment of patients with musculoskeletal connective tissue fibrosis or a disorder including Dupuytren's Contracture, Peyronie's disease, Ledderhose disease, or Knuckle Pads, includes an active composition and a base composition. The active composition is present in the transdermal composition in an amount of about 10% to about 40% by weight of the transdermal composition and includes one or more growth factor antagonists. The base composition is present in an amount of about 60% to about 90% by weight of the transdermal composition and comprises a transdermal delivery system or transdermal carrier. A method of treating patients with musculoskeletal connective tissue fibrosis, including topically applying the transdermal composition in effective amount to the affected tissue is further disclosed. 20

Claim (Index 8):
The transdermal composition of  claim 6 , wherein the base composition comprises a phospholipid base.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 94.0
- Lexical Diversity: 2.10606
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14981167', '13747151', '14610875', '15177760', '15831650']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7457827848943681
- 35 USC 102 Novelty (BERT): 0.4837442545214742
- Combined Prediction Score: 0.7195789318570788
- Mean Citation Score: 175.113236
- Max Citation Score: 179.13127
- Similarity Product: 128.39787309984922

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test